An interventional study of diclofenac drops and dexamethasone sodium phosphate 0.1% eye drops in Glaucoma and Cataract, sponsored by Sheba Medical Center. Completed at 1 site in Israel. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2009-01-21.
Sponsored by Sheba Medical Center · Not applicable, Interventional, and Treatment
To study the effect of Diclofenac drops or Dexamethasone drops on combined surgery of trabeculectomy and cataract surgery.
1,701 studies on the registry are indexed under Cataract; 230 are open to participants now.
This study's planned enrollment of 50 is below the median of 80 across 1,155 interventional studies indexed under Cataract.
Browse Cataract studies →Sheba Medical Center is the lead sponsor of 660 studies on the registry; 63 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
four times a day for 3 months
Drug: diclofenac drops
Drug: dexamethasone sodium phosphate 0.1% eye drops
one drop 4 times a day for 3 months
for first week after the operation : one drop 6 times a day. Then tapering by reducing one drop for a week
intraocular pressure
Time frame: year
the number of antiglaucoma medications
Time frame: year
This study is completed, as verified in Jan 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sheba Medical Center